The Regional Blockbuster: When European Partners Shine
Executive Summary
Broadly speaking, Europe accounts for far less blockbuster drug revenue than the US, particularly in mass market categories where direct-to-consumer advertising is important. But Europe does provide its fair share of blockbuster sales in many areas that biotechs focus on, such as HIV, according to IMS Global Consulting.